Literature DB >> 9932948

Changing epidemiology of Parkinson's disease in southwestern Finland.

A M Kuopio1, R J Marttila, H Helenius, U K Rinne.   

Abstract

OBJECTIVE: Investigation of the epidemiology of PD in southwestern Finland in 1992 (population 196,864), including urban and rural areas, with a comparison with a similar study, done in the same area in 1971, to evaluate the temporal pattern.
METHODS: Community-based method of patient ascertainment with personal investigation of cases.
RESULTS: The age-adjusted prevalence (to the Finnish general population in 1991) was 139 per 100,000 population in 1971 and 166 in 1992. Prevalence ratio for PD in men versus women was 1.2 (NS) in 1971 and 1.7 in 1992 (p < 0.001); in the rural versus urban populations the prevalence ratio was 0.8 (NS) in 1971 and 1.3 in 1992 (p = 0.013). The age-specific prevalence rates showed a male preponderance in all age groups in 1992 and a rural preponderance in the age groups over 60 years. In 1992, compared with 1971, the male and rural preponderance occurred in the age groups over 70 years. The age-adjusted incidence was 15.7 per 100,000 population in 1971 and 14.9 in 1992. Relative risk for PD in men versus women was 0.9 (NS) in 1971 and 1.9 (p < 0.001) in 1992, and in rural versus urban populations 1.4 (p = 0.093) in 1992.
CONCLUSIONS: A very significant male and a significant rural predominance, not seen in 1971, suggests a possible environmental causative factor, perhaps more frequent in the rural environment, associated with PD. Men may be either more exposed to it or more susceptible to its effects than women.

Entities:  

Mesh:

Year:  1999        PMID: 9932948     DOI: 10.1212/wnl.52.2.302

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

2.  Gender and the Parkinson's disease phenotype.

Authors:  Yasuhiko Baba; John D Putzke; Nathaniel R Whaley; Zbigniew K Wszolek; Ryan J Uitti
Journal:  J Neurol       Date:  2005-09-12       Impact factor: 4.849

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

4.  Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.

Authors:  Susan E Best; Philip M Sarrel; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; John P Seibyl; Robert B Innis; Christopher H van Dyck
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

5.  Parkinsonism and occupational exposure to pesticides.

Authors:  L S Engel; H Checkoway; M C Keifer; N S Seixas; W T Longstreth; K C Scott; K Hudnell; W K Anger; R Camicioli
Journal:  Occup Environ Med       Date:  2001-09       Impact factor: 4.402

6.  Efficient whole-genome association mapping using local phylogenies for unphased genotype data.

Authors:  Zhihong Ding; Thomas Mailund; Yun S Song
Journal:  Bioinformatics       Date:  2008-07-30       Impact factor: 6.937

7.  Incidence and remaining lifetime risk of Parkinson disease in advanced age.

Authors:  Jane A Driver; Giancarlo Logroscino; J Michael Gaziano; Tobias Kurth
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

8.  Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Authors:  Todd L Edwards; William K Scott; Cherylyn Almonte; Amber Burt; Eric H Powell; Gary W Beecham; Liyong Wang; Stephan Züchner; Ioanna Konidari; Gaofeng Wang; Carlos Singer; Fatta Nahab; Burton Scott; Jeffrey M Stajich; Margaret Pericak-Vance; Jonathan Haines; Jeffery M Vance; Eden R Martin
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

9.  Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.

Authors:  Andreas Plaitakis; Helen Latsoudis; Konstantinos Kanavouras; Beate Ritz; Jeff M Bronstein; Irene Skoula; Vasileios Mastorodemos; Spyridon Papapetropoulos; Nikolas Borompokas; Ioannis Zaganas; Georgia Xiromerisiou; George M Hadjigeorgiou; Cleanthe Spanaki
Journal:  Eur J Hum Genet       Date:  2009-10-14       Impact factor: 4.246

10.  Parkinson's disease and low frequency alleles found together throughout LRRK2.

Authors:  Coro Paisán-Ruiz; Nicole Washecka; Priti Nath; Andrew B Singleton; Elizabeth H Corder
Journal:  Ann Hum Genet       Date:  2009-05-21       Impact factor: 1.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.